FREE Account Opening + No Clearing Fees
Loading...

GI Engineering Solutions Rights Issue 2023 vs Piramal Pharma Rights Issue 2023

Comparision between GI Engineering Solutions Rights Issue 2023 and Piramal Pharma Rights Issue 2023.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for GI Engineering Solutions Rights Issue 2023 and Piramal Pharma Rights Issue 2023. GI Engineering Solutions Rights Issue 2023 is listed on BSE, NSE while Piramal Pharma Rights Issue 2023 is listed on BSE, NSE.

  GI Engineering Solutions Limited Piramal Pharma Limited
Logo GI Engineering Solutions Rights Issue 2023 Logo Piramal Pharma Rights Issue 2023 Logo
Listing At BSE, NSE BSE, NSE
Terms of Payment

Full amount of Rs. 10/- per Equity Share payable on application.

The full amount of Rs. 81 for rights equity shares has to be paid on application.

Entitlement 11 Rights Equity Share(s) for every 8 fully paid-up Equity Shares held on Record Date 5 Rights Equity Share(s) for every 46 fully paid-up Equity Shares held on Record Date
Application Form Application Form Application Form
Letter of Offer Letter of Offer Letter of Offer
Registrar Bigshare Services Pvt Ltd Link Intime India Private Ltd
Lead Managers ICICI Securities Limited

Rights Issue Size and Price

The issue size of GI Engineering Solutions Rights Issue 2023 rights issue is ₹49.86 Crores, whereas Piramal Pharma Rights Issue 2023 rights issue size is ₹1,050.00 Crores.

  GI Engineering Solutions Limited Piramal Pharma Limited
Issue Size 4,98,60,082 shares 12,96,29,630 shares
Issue Size (Amount) ₹49.86 Crores ₹1,050.00 Crores
Issue Price ₹10 per share ₹81 per share
Face Value ₹10 per share ₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of GI Engineering Solutions Rights Issue 2023 is Apr 18, 2023 while record date of Piramal Pharma Rights Issue 2023 is Aug 02, 2023.

  GI Engineering Solutions Limited Piramal Pharma Limited
Record Date Apr 18, 2023 Aug 02, 2023
Credit of Rights Entitlements
Bid/Offer Opens On Apr 27, 2023 Aug 08, 2023
Renunciation of Rights Entitlements May 03, 2023 Aug 10, 2023
Bid/Offer Closes On May 09, 2023 Aug 17, 2023
Deemed Date of Allotment Aug 23, 2023
Credit Date Aug 24, 2023
Listing Date Aug 28, 2023

Financials details

Comparison of GI Engineering Solutions Rights Issue 2023 and Piramal Pharma Rights Issue 2023 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

  GI Engineering Solutions Limited Piramal Pharma Limited
Financial
GI Engineering Solutions Limited Financial Information (Restated Standalone)
Period EndedTotal AssetsTotal RevenueProfit After Tax
31-Mar-1814.240.020.09
31-Mar-198.280.05-0.08
31-Mar-209.160.12-0.04
31-Mar-214.590.20-2.52
31-Mar-224.440.110.01
Amount in ₹ Crore
Piramal Pharma Rights Issue 2023 Financial Information (Restated Consolidated)
Period Ended31 Mar 202131 Mar 202231 Mar 2023
Assets10,899.7812,797.0414,522.56
Revenue6,479.016,834.907,306.66
Profit After Tax835.03375.96-186.46
Net Worth5,076.756,069.945,968.45
Reserves and Surplus4,488.625,290.695,181.79
Total Borrowing2,910.194,023.285,504.77
Amount in ₹ Crore

Comments

Add a public comment...